(WWSB) - 35 years ago, a pair of scientists made a discovery that they believed would change Alzheimer’s research forever.

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...

Researchers at UCLA Health have discovered a molecule that shows promise in restoring memory and cognitive function in mice ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...

"There are currently no approved treatments for DLB, so doctors often use drugs for Alzheimer's disease, such as ...

Laboratory mice with cognitive issues including Alzheimer's disease showed improved memory skills within a couple of weeks of ...

Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.

If the European Medicines Agency takes an overly cautious approach to selecting specialists to advise on new medicines, ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...